Structure and absolute configuration of nebivolol : (±)-(R*{S*[S*-(S*)]})-α,α'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)
- Author
- PEETERS, O. M; BLATON, N. M; DE RANTER, C. J
Katholieke univ. Leuven, inst. farmaceutische wetenschappen, lab. analytische chemie madicinale, 3000 Leuven, Belgium - Source
Acta crystallographica. Section C, Crystal structure communications. 1993, Vol 49, pp 2154-2157 ; 12 ; ref : 16 ref
- CODEN
- ACSCEE
- ISSN
- 0108-2701
- Scientific domain
- Crystallography
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Amine secondaire Bromhydrate Chlorhydrate Composé bicyclique Configuration absolue Diol Etude expérimentale Hydrate Hétérocycle oxygène Liaison hydrogène Nébivolol Racémique Structure cristalline Structure moléculaire XRD Composé organique Fluor Composé organique
- Keyword (en)
- Secondary amine Hydrobromides Hydrochlorides Bicyclic compound Absolute configuration Diol Experimental study Hydrates Heterocyclic oxygen compounds Hydrogen bonds Racemates Crystal structure Molecular structure XRD Organic compounds Fluorine Organic compounds
- Keyword (es)
- Amina secundaria Hidrobromuro Hidrocloruro Compuesto bicíclico Configuración absoluta Diol
- Classification
- Pascal
- 001 Exact sciences and technology / 001B Physics / 001B60 Condensed matter: structure, mechanical and thermal properties / 001B60A Structure of solids and liquids; crystallography / 001B60A10 X-ray diffraction and scattering / 001B60A10N Single-crystal and powder diffraction
- Pascal
- 001 Exact sciences and technology / 001B Physics / 001B60 Condensed matter: structure, mechanical and thermal properties / 001B60A Structure of solids and liquids; crystallography / 001B60A66 Structure of specific crystalline solids / 001B60A66H Organic compounds / 001B60A66H3 Heterocyclic compounds
- Discipline
- Physics of condensed state : structure, mechanical and thermal properties
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3889431
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1107/S0108270193006687 
https://dx.doi.org/10.1107/S0108270193006687
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1107\/S0108270193006687\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:9:\"\u0000*\u0000jtitle\";s:67:\"Acta crystallographica. Section C, Crystal structure communications\";s:9:\"\u0000*\u0000stitle\";s:42:\"Acta crystallogr., C Cryst. struct. commun\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2154\";s:8:\"\u0000*\u0000epage\";s:4:\"2157\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0108-2701\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PEETERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"O. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:12:\"BLATON, N. M\";i:1;s:15:\"DE RANTER, C. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACSCEE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:2:\"12\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1107\/S0108270193006687\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:9:\"\u0000*\u0000jtitle\";s:67:\"Acta crystallographica. Section C, Crystal structure communications\";s:9:\"\u0000*\u0000stitle\";s:42:\"Acta crystallogr., C Cryst. struct. commun\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2154\";s:8:\"\u0000*\u0000epage\";s:4:\"2157\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0108-2701\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PEETERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"O. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:12:\"BLATON, N. M\";i:1;s:15:\"DE RANTER, C. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACSCEE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:2:\"12\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1107\/S0108270193006687\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1107\/S0108270193006687\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:9:\"\u0000*\u0000jtitle\";s:67:\"Acta crystallographica. Section C, Crystal structure communications\";s:9:\"\u0000*\u0000stitle\";s:42:\"Acta crystallogr., C Cryst. struct. commun\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2154\";s:8:\"\u0000*\u0000epage\";s:4:\"2157\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0108-2701\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PEETERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"O. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:12:\"BLATON, N. M\";i:1;s:15:\"DE RANTER, C. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACSCEE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:2:\"12\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1107\/S0108270193006687\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:9:\"\u0000*\u0000jtitle\";s:67:\"Acta crystallographica. Section C, Crystal structure communications\";s:9:\"\u0000*\u0000stitle\";s:42:\"Acta crystallogr., C Cryst. struct. commun\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2154\";s:8:\"\u0000*\u0000epage\";s:4:\"2157\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0108-2701\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PEETERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"O. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:12:\"BLATON, N. M\";i:1;s:15:\"DE RANTER, C. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACSCEE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:2:\"12\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1107\/S0108270193006687\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:9:\"\u0000*\u0000jtitle\";s:67:\"Acta crystallographica. Section C, Crystal structure communications\";s:9:\"\u0000*\u0000stitle\";s:42:\"Acta crystallogr., C Cryst. struct. commun\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"49\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:4:\"2154\";s:8:\"\u0000*\u0000epage\";s:4:\"2157\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0108-2701\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PEETERS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"O. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:12:\"BLATON, N. M\";i:1;s:15:\"DE RANTER, C. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACSCEE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:2:\"12\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:245:\"Structure and absolute configuration of nebivolol : (\u00b1)-(R*{S*[S*-(S*)]})-\u03b1,\u03b1'-[iminobis(methylene)]bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol) (nebivolol) hydrochloride (I) and (+)-(S{R[R-(R)]})-nebivolol hydrobromide dihydrate (II)\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
